Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Trading exchanges
Trading exchanges
NASDAQ
Products 41 to 50 of 69
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Mirel P1003, F1005 for Injection Molding
by
Yield10 Bioscience
Biotech components:
Plant
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
41,800,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
No longer on the market
Organization type(s):
Public Company
Product categories:
Fiber
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
YTEN
(NASDAQ)
Value chain stage:
Input
Mirel P1004, F1006 for Injection Molding
by
Yield10 Bioscience
Biotech components:
Plant
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
41,800,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
No longer on the market
Organization type(s):
Public Company
Product categories:
Fiber
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
YTEN
(NASDAQ)
Value chain stage:
Input
Muck Daddy (TM)
by
Amyris
Biotech components:
Plant
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
Commercial
+
Consumer
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/10/01 09:47 (7 years ago)
Known funding amount:
471,900,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
No longer on the market
Organization type(s):
Public Company
Product categories:
Personal Care (Topical)
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
AMRS
(NASDAQ)
Value chain stage:
Finished Product
Myralene Renewable Solvent
by
Amyris
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/10/02 11:37 (7 years ago)
Known funding amount:
471,900,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
No longer on the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
AMRS
(NASDAQ)
Value chain stage:
Input
Neossance Hemisqualane
by
Aprinnova
Biotech components:
Plant
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
+
Japan
+
Europe
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
471,900,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Personal Care (Topical)
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
AMRS
(NASDAQ)
Value chain stage:
Finished Product
Neossance Squalane
by
Aprinnova
Biotech components:
Plant
Business models:
B2C
Country of production:
USA
Country of distribution:
Australia
+
Canada
+
China
+
Europe
+
Japan
+
Korea
+
Mexico
+
New Zealand
+
Philippines
+
Russia
+
USA
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
471,900,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Personal Care (Topical)
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
AMRS
(NASDAQ)
Value chain stage:
Finished Product
Non-browning avocado
by
Intrexon
Biotech components:
Gene Editing
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 14:31 (6 years ago)
Date last modified:
2019/09/12 14:31 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Food
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
Non-browning cherries
by
Intrexon
Biotech components:
Gene Editing
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:10 (6 years ago)
Date last modified:
2019/09/12 15:10 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Food
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
Non-browning Pears
by
Intrexon
Biotech components:
Gene Editing
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:11 (6 years ago)
Date last modified:
2019/09/12 15:11 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Food
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
PRGN-3005: Cancer
by
Intrexon
Biotech components:
Gene Editing
+
Molecule
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 14:31 (6 years ago)
Date last modified:
2019/09/12 14:31 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Medical
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
1
2
3
4
5
6
7
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
